The M6-C artificial cervical disc was designed by Spinal Kinetics and acquired by Orthofix in April 2018.

Orthofix has released three- and four-year preliminary outcomes from its M6-C artificial cervical disc single-level clinical trial.

In the first quarter, Bioventus saw year-over-year net income growth and a $45 million acquisition. 

Think Surgical and Ortho Development have received FDA clearance to use Ortho Development's knee system and implants with Think Surgical's total knee active robot system. 

Here are six updates from spine and orthopedic device companies over the last week:

Richard Weiner, MD, a spine surgeon in Dallas, and John Czerwein, MD, a spine surgeon in Providence, R.I. were among the first to debut Life Spine's Trulift expandable spacer system.

Surgalign's gross profit and revenue decreased in the first quarter of this year compared to the same period last year.

Here are six executive appointments from spine and orthopedic device companies in the last two months.

The FDA cleared 13 spine devices in April.

Juliet Cunningham was named vice president of investor relations at spine device company NuVasive.

Orthofix received 510(k) clearance from the FDA for its OrthoNext digital platform for pediatric orthopedic planning.

Confirmis' Identity Imprint knee replacement system received 510(k) clearance from the FDA.

Surgalign Spine Technologies has submitted a premarket notification 510(k) to the FDA for approval of its digital surgical guidance system.

The FDA cleared 36 musculoskeletal devices in April.

The first augmented-reality-assisted total knee replacement with Medacta's NextAR system was performed in December, and now the medtech company aims to expand the technology to spine, hip and shoulder surgery.

Surgalign Spine Technologies has purchased a medical device manufacturing facility to compliment its Spine Innovation Center operations in San Diego.

Spine device company Alphatec reported $44.1 million in first-quarter revenue, an increase of 50 percent compared to the first quarter of 2020.

Steven Goldberg, MD, an orthopedic surgeon at Physicians Regional Medical Center in Naples, Fla., and Zachary Leitze, MD, an orthopedic surgeon with Intermountain Medical Group in St. George, Utah, were among the first surgeons to use Catalyst OrthoScience's Archer R1 reverse shoulder system, Catalyst said this week.

NuVasive saw an increase in net sales, but a decrease in net income during the first quarter of 2021.

Here are seven updates from spine and orthopedic device companies from the last week: